Skip to main content
OpenTrials
Completed

NCT Number: NCT04983056

Management of Fournier Gangrene at Ibn Rochd University Hospital Center

Case series with retrospective data collection of patients treated for Fournier's gangrene between January 2010 and March 2017. The main etiologies, risk factors, postoperative complications outcomes and long term follow up results were analyzed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Fournier Gangrene Bacterial Infections Bacterial Infections and Mycoses Genital Diseases Genital Diseases, Male Infections Male Urogenital Diseases Urogenital Diseases

Age range

15 year–100 year

Sex eligibility

All sexes

Study type

Observational

About this study

Eight four (84) patients were recruited. The average age of our patients was 49 years (with limits of 20 to 76), the male gender dominates our series (83.33%) with a sex ratio of 5M / 1W, the most frequently found risk factor was diabetes mellitus (37%). The most common etiology was anal abscesses (32%). The average time to consultation was 8 days (limits ranges from 3 to 30 days). All patients were admitted at a necrosis stage (100%). Anemia was identified in 85% of cases. The low platelets were noticed in 44.03% of cases. Hypoalbuminemia was found in 93% of cases. All patients (100%) benefited resuscitation initially and antibiotic therapy on their admission. They received emergency surgical debridement with a cleansing stoma. The average length of hospital stay was 13 days and complications occurred in 33% of cases. The mortality rate was 7.14%. then we conclude that Fournier's gangrene is a medico-surgical emergency with a high morbidity and mortality rate. Early diagnosis as well as antibiotic therapy and the quality of debridement save the patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of Fournier Gangrene

Exclusion criteria

  • Other perineal diseases which are differential diagnosis of Fournier gangrene

Treatment and study plan

Necrotesectomy associated with cleanleness stoma

Procedure

Excision of all necrotised tissues after stool diversion and wound dressing using

Primary outcomes

  1. Number of patients who died for fournier gangrene

    Time frame: Six months

    The mortality rate of patients with Fournier Gangrene after six months

Sponsors and collaborators

Lead sponsor

Sylvestre KABURA

Other

Registry information

Official study title

Fournier's Gangrene: Seven Years of Experience in the Emergencies Service of Visceral Surgery at Ibn Rochd UHC

Important dates

Study start
2010
Primary completion
2017
Study completion
2021
First posted
Jul 30, 2021
Registry last updated
Jul 30, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.